Atai Life Sciences N.V. (ATAI)

Atai Life Sciences Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	1.86	0.31	0.31	0.23	20.38	-
Revenue Growth (YoY)	572.56%	-1.91%	34.76%	-98.86%	-	-
Gross Profit	2.26	0.31	0.31	0.23	20.38	-
Selling, General & Admin	45	45.97	62.18	70.35	92.75	80.73
Research & Development	54.11	54.11	60.4	74.31	47.96	11.41
Operating Expenses	99.11	100.08	122.59	144.66	140.7	92.14
Operating Income	-96.86	-99.77	-122.27	-144.43	-120.33	-92.14
Interest Expense	-3.34	-3.12	-2.66	-0.92	-	-
Interest & Investment Income	0.66	0.78	1.85	0.55	0.21	0.07
Earnings From Equity Investments	-0.3	-2	-3.59	-16.01	-58.56	-76.51
Currency Exchange Gain (Loss)	-0.59	-1.26	-0.89	6.9	8.48	-0.19
Other Non Operating Income (Expenses)	-12.57	-9.06	-1.61	-0.21	-0.34	0.01
EBT Excluding Unusual Items	-113	-114.45	-129.17	-154.12	-170.53	-168.77
Merger & Restructuring Charges	-1.2	-2	-3.2	-	-	-
Gain (Loss) on Sale of Investments	-41.6	-40.4	86.29	0.3	4.58	19.86
Gain (Loss) on Sale of Assets	4.63	4.63	0.16	1.48	-	-
Asset Writedown	-0.92	-0.92	-	-	-	-
Other Unusual Items	2.4	2.2	0.6	1.5	3.2	-17.39
Pretax Income	-149.68	-150.93	-45.32	-151.19	-178.23	-178.32
Income Tax Expense	-0.54	-0.88	-1.43	6.23	-3.99	0.31
Earnings From Continuing Operations	-149.14	-150.05	-43.9	-157.42	-174.24	-178.63
Minority Interest in Earnings	0.15	0.78	3.67	5.03	6.44	8.78
Net Income	-148.99	-149.27	-40.22	-152.39	-167.81	-169.84
Net Income to Common	-148.99	-149.27	-40.22	-152.39	-167.81	-169.84
Shares Outstanding (Basic)	165	160	159	156	138	93
Shares Outstanding (Diluted)	165	160	159	156	138	93
Shares Change (YoY)	3.07%	0.83%	2.00%	12.62%	48.64%	973.40%
EPS (Basic)	-0.91	-0.93	-0.25	-0.98	-1.21	-1.83
EPS (Diluted)	-0.91	-0.93	-0.25	-0.98	-1.21	-1.83
Free Cash Flow	-78.73	-82.44	-84.38	-105.24	-64.42	-20.83
Free Cash Flow Per Share	-0.48	-0.52	-0.53	-0.68	-0.47	-0.22
Gross Margin	121.04%	100.00%	100.00%	100.00%	100.00%	-
Operating Margin	-5198.98%	-32393.51%	-38939.81%	-61987.12%	-590.52%	-
Profit Margin	-7997.15%	-48463.96%	-12810.19%	-65401.29%	-823.56%	-
Free Cash Flow Margin	-4225.93%	-26767.21%	-26871.66%	-45167.38%	-316.15%	-
EBITDA	-96.25	-99.3	-121.95	-144.26	-120.28	-92.12
D&A For EBITDA	0.61	0.47	0.32	0.17	0.05	0.02
EBIT	-96.86	-99.77	-122.27	-144.43	-120.33	-92.14

Updated May 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q